Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Lung Neoplasms 5Small Cell Lung Carcinoma 4Mesothelioma 3Neoplasms 2Neoplasm Metastasis 2Mesothelioma, Malignant 2Carcinoma, Non-Small-Cell Lung 2Uveal Melanoma 1Urologic Neoplasms 1Stomach Neoplasms 1SCLC,Extensive Stage 1Recurrence 1Pancreatic Neoplasms 1Melanoma 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1Colonic Neoplasms 1Cholangiocarcinoma 1Carcinoma, Squamous Cell 1Carcinoma, Renal Cell 1Carcinoma, Neuroendocrine 1Carcinoma 1Breast Neoplasms 1Anus Neoplasms 1

Interventions

pembrolizumab 5tislelizumab 2spartalizumab 2Trastuzumab 2Psychiatric Rehabilitation 2Nivolumab 2Magnetic Resonance Spectroscopy 2Interleukin-12 Subunit p35 2Erlotinib Hydrochloride 2Biopsy 2trastuzumab deruxtecan 1tipifarnib 1regorafenib 1prexasertib 1niraparib 1fludarabine 1enzalutamide 1entinostat 1abiraterone 1Vorinostat 1Thalidomide 1Taxes 1Surveys and Questionnaires 1Specimen Handling 1Ritonavir 1Radiotherapy 1Radionuclide Imaging 1Quality of Life 1Patient Reported Outcome Measures 1Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anus Neoplasms × niraparib × Thoracic × Clear all
NCT03221400 2022-02-17

PEN-866 in Patients With Advanced Solid Malignancies

Tarveda Therapeutics

Phase 1/2 Unknown
340 enrolled
GastrointestinalThoracic

Anus Neoplasms, Carcinoma, Carcinoma, Squamous Cell, Neoplasms, Stomach Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡